Clinical Trial: First in Human Study of TLC-ART 101 (ACTU 2001)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Human Immunodeficiency Virus
Study Type: INTERVENTIONAL
Official Title: First in Human Clinical Trial of a Next Generation, Long-acting Injectable, Combination Antiretroviral Therapy Platform
Brief Summary:
This study is a prospective, open-label, single-site, first-in-human study of a long-acting, injectable combination antiretroviral therapy platform, with a pharmacologically-guided adaptive design for dose escalation, de-escalation, and study duration.The study is designed to learn whether the formulation can be used as a platform for other drugs for treatment of HIV.The formulation is a drug combination nanoparticle (DCNP).The study will be conducted by UW Positive Research.The sample size for this study is…
Read more